Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR-FGFR1 fusion

por Qiu, Xu-Hua, Li, Feng, Cao, Hong-Qin, Shao, Jing-Jing, Mei, Jian-Gang, Li, Han-Qing, Zhai, Yong-Ping
Publicado 2017